Difference between revisions of "Category:Malignant solid neoplasm, BRAF-mutated medications"
Jump to navigation
Jump to search
(Created page with "Medications with some degree of efficacy in the treatment of BRAF-mutated tumors, regardless of anatomic site of origin. Category:Site-agnostic medications") |
m (Jwarner moved page Category:BRAF medications to Category:Malignant solid neoplasm, BRAF-mutated medications) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
− | Medications with some degree of efficacy in the treatment of BRAF-mutated tumors, regardless of anatomic site of origin. | + | Medications with some degree of efficacy in the treatment of [[BRAF|BRAF-mutated tumors]], regardless of anatomic site of origin. |
[[Category:Site-agnostic medications]] | [[Category:Site-agnostic medications]] |
Latest revision as of 15:15, 21 September 2023
Medications with some degree of efficacy in the treatment of BRAF-mutated tumors, regardless of anatomic site of origin.
Pages in category "Malignant solid neoplasm, BRAF-mutated medications"
The following 3 pages are in this category, out of 3 total.